Clinical Trial

Registry Platform Gastric/Esophageal Cancer (SAPHIR)

Study acronym: SAPHIR
Recruiting
View on ClinicalTrials.gov →
Summary
The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-02-27; most recent amendment 2026-01-26.
Trial Details
NCT Number NCT04290806
Lead Sponsor iOMEDICO AG
Conditions Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
Enrollment 1,900 participants
Start Date 2019-12-04
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-28